Sale!

Immunohistochemistry Calcitonin Test

Original price was: $126.Current price is: $76.

-40%

The Immunohistochemistry Calcitonin Test is a specialized diagnostic procedure that detects calcitonin protein expression in tissue samples, primarily used for diagnosing and confirming medullary thyroid carcinoma. This advanced immunohistochemical analysis provides crucial information about tumor characteristics and helps differentiate between various thyroid cancer types. The test is essential for patients with suspicious thyroid nodules, elevated serum calcitonin levels, or family history of endocrine tumors. By identifying calcitonin-producing cells, physicians can make accurate diagnoses and develop targeted treatment plans. The procedure costs $76 USD with our current discount, offering significant savings from the regular $126 price. Results are typically available within 5-7 days, providing timely information for critical medical decisions.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

Immunohistochemistry Calcitonin Test: Advanced Thyroid Cancer Detection

Understanding the Immunohistochemistry Calcitonin Test

The Immunohistochemistry Calcitonin Test represents a cornerstone in modern cancer diagnostics, specifically designed to detect and quantify calcitonin protein expression in tissue samples. This sophisticated laboratory technique utilizes specific antibodies that bind to calcitonin molecules, allowing pathologists to visualize and assess the presence of this crucial hormone marker within cellular structures. The test’s precision makes it invaluable for confirming medullary thyroid carcinoma diagnoses and distinguishing between different thyroid tumor types.

Calcitonin, a hormone produced by C-cells in the thyroid gland, serves as a specific biomarker for medullary thyroid cancer. When these cells become cancerous, they often produce excessive amounts of calcitonin, which can be detected through immunohistochemical staining. This test provides visual confirmation of calcitonin production at the cellular level, offering insights that serum blood tests alone cannot provide.

What the Test Measures and Detects

The Immunohistochemistry Calcitonin Test specifically identifies:

  • Calcitonin protein expression in thyroid tissue samples
  • Presence and distribution of C-cells within thyroid specimens
  • Patterns of calcitonin staining that indicate medullary thyroid carcinoma
  • Differentiation between medullary thyroid cancer and other thyroid tumors
  • Intensity and extent of calcitonin production in suspicious lesions

This test employs advanced immunohistochemical techniques where tissue sections are treated with specific anti-calcitonin antibodies. These antibodies bind to calcitonin molecules present in the tissue, and subsequent staining reactions make the bound antibodies visible under microscopy. The resulting pattern provides critical diagnostic information about the nature and behavior of thyroid tumors.

Who Should Consider This Test

Clinical Indications and Symptoms

This test is recommended for individuals experiencing:

  • Palpable thyroid nodules or neck masses
  • Elevated serum calcitonin levels in blood tests
  • Family history of medullary thyroid cancer or multiple endocrine neoplasia (MEN) syndromes
  • Suspicious thyroid ultrasound findings requiring tissue confirmation
  • Unexplained diarrhea or flushing symptoms associated with calcitonin excess
  • Previous diagnosis of C-cell hyperplasia
  • Monitoring of recurrent medullary thyroid carcinoma

Risk Factors and Screening Criteria

Patients with the following risk profiles should particularly consider this test:

  • Known RET proto-oncogene mutations
  • Family members diagnosed with medullary thyroid cancer
  • Multiple endocrine neoplasia type 2A or 2B carriers
  • Patients with unexplained elevated calcitonin levels
  • Individuals with rapidly growing thyroid nodules

Benefits of Taking the Immunohistochemistry Calcitonin Test

Undergoing this specialized diagnostic procedure offers numerous advantages:

Accurate Diagnosis and Classification

The test provides definitive evidence of medullary thyroid carcinoma, enabling precise tumor classification and appropriate treatment planning. By confirming calcitonin production at the tissue level, physicians can make confident diagnoses that guide surgical and medical management decisions.

Early Detection Capabilities

Early identification of medullary thyroid cancer through calcitonin immunohistochemistry can significantly impact treatment outcomes. Detecting these tumors in their initial stages allows for less extensive surgical interventions and improved long-term prognosis.

Treatment Guidance

Results from this test directly influence therapeutic approaches. Positive calcitonin staining confirms the need for total thyroidectomy and central neck dissection, while negative results may suggest alternative diagnoses requiring different management strategies.

Prognostic Information

The intensity and pattern of calcitonin staining can provide valuable prognostic information. Strong, diffuse staining typically correlates with more aggressive tumor behavior, helping clinicians tailor follow-up protocols and surveillance strategies.

Understanding Your Test Results

Interpretation Guidelines

Test results are typically categorized as follows:

Positive Result

A positive result indicates strong calcitonin staining in tumor cells, confirming medullary thyroid carcinoma. This finding necessitates comprehensive surgical management and long-term monitoring for recurrence.

Negative Result

Negative staining suggests the absence of medullary thyroid cancer. However, interpretation must consider clinical context, as poorly differentiated tumors may lose calcitonin expression.

Focal or Weak Staining

Focal or weak calcitonin expression may indicate C-cell hyperplasia or early medullary carcinoma, requiring correlation with serum calcitonin levels and clinical findings.

Clinical Correlation

Results should always be interpreted in conjunction with:

  • Serum calcitonin levels
  • Thyroid ultrasound findings
  • Clinical presentation and symptoms
  • Family history and genetic testing results
  • Other immunohistochemical markers

Test Pricing and Availability

Price Type Amount (USD) Details
Discount Price $76 Limited time offer – Save $50
Regular Price $126 Standard pricing

Turnaround Time

  • Sample Processing: Daily by 6 PM
  • Standard Tissue Biopsy: 5 days
  • Tissue Block: 5 days
  • Large Complex Tissue: 7 days

Sample Requirements

For accurate testing, please provide:

  • Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block
  • Ship samples at room temperature
  • Include copy of Histopathology report
  • Provide Site of biopsy information
  • Submit complete Clinical history

Nationwide Availability

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, and many other cities. Our network of certified laboratories ensures consistent, high-quality results regardless of your location.

Take Action for Your Health

Don’t delay critical diagnostic testing. The Immunohistochemistry Calcitonin Test provides essential information for managing thyroid health and detecting potentially serious conditions early. Our team of experienced oncologists and pathologists are ready to assist you with comprehensive testing and expert interpretation.

Call us today at +1(267) 388-9828 to schedule your test or speak with our medical professionals about your testing needs. Early detection saves lives – take the first step toward accurate diagnosis and proper treatment.

Our dedicated customer service team is available to answer your questions, explain the testing process, and help you understand what to expect. We accept most major insurance plans and offer flexible payment options to make this essential testing accessible to all patients.